Publications by authors named "Gongzhang Su"
Esophageal cancer (ESCA) progression and chemoresistance are critical factors that impact the survival of patients with esophageal cancer. Cyclin dependent kinase inhibitor 3 (CDKN3) is an important regulator of the cell cycle that has received little attention, therefore the purpose of this study was to investigate CDKN3 involvement in ESCA. We first explored the public database in addition to our cohort to evaluate the expression of CDKN3 in ESCA patients.
View Article and Find Full Text PDFTargeted therapy is commonly used for treating advanced malignant tumors. Compared with cytotoxic drugs, targeted drugs have the characteristics of good curative results, less adverse effects, and convenient oral administration. Hence, they are especially suitable for patients with cancer who are not able to tolerate chemotherapy.
View Article and Find Full Text PDFLipoma-Like Bronchogenic Cyst in the Right Chest Sidewall: A Case Report and Literature Review.
Ann Thorac Cardiovasc Surg
December 2016
Article Synopsis
- - A 59-year-old female was admitted with a bronchogenic cyst located unusually on the right chest wall, rather than in the mediastinum or lung.
- - A preoperative CT scan identified the cyst as a low-density lesion, which was successfully removed using thoracoscopic surgery.
- - Pathological examination confirmed the lesion as a bronchogenic cyst, distinct from fat tissue (lipoma), and the study also reviewed previous cases to enhance clinical understanding.
Objective: To explore the clinical application of recombinant human endostatin (Endostar) in the treatment of patients with non-small cell lung cancer (NSCLC) in Chinese mainland.
Materials And Methods: A total of 75 patients diagnosed as NSCLC were randomly divided into control group (37 cases) and treatment group (38 cases). Control group was treated with postoperative complementary chemotherapy containing two-agent platinum protocol on postoperative d21, 3 weeks as a cycle, for totally 4~6 cycles.